EPN — Epsilon Healthcare Share Price
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -39.36% | ||
| Return on Equity | -60.1% | ||
| Operating Margin | -66.06% | ||
Financial Summary
| Year End 31st Dec | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | AU$m | 2.66 | 4.79 | 6.95 | 5.5 | 7.11 | n/a | n/a | 30.99% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Epsilon Healthcare Limited is an Australia-based global healthcare and pharmaceuticals company. The Company has a diversified and vertically integrated portfolio of assets, including healthcare and pharmaceutical contract development and manufacturing. The Company’s segments include the manufacture and distribution of hydroponics equipment, materials and nutrients, and the development and delivery of medicinal cannabis. The Company owns medicinal cannabis assets, including the GMP cannabis manufacturing facility in the Southern Hemisphere (the Southport Facility) in Southport, Australia, and the Tetra Health clinic group. The Company also provides advisory services related to medicinal cannabis. The Company’s subsidiaries include Dragon Vision Limited, Canndeo Pty Ltd, Canna Clinics Pty Ltd, THC Pharma Pty Ltd, Metra Holdings Pty Ltd, Tetra Pty Ltd, Medimar Pty Ltd and Demimar Pty Ltd.
Directors
- Alan Beasley CHM
- Steven Xu CHM
- Jarrod White CEO
- Sonny Didugu COO
- Jason Colquhoun EXO
- Laura Harvey EXO
- Diandra Phipps EXO
- Henry Kinstlinger SEC
- Philip Leighfield SEC
- Lou Anthony Cattelan NED
- Last Annual
- December 31st, 2022
- Last Interim
- June 30th, 2023
- Incorporated
- August 29th, 2016
- Public Since
- May 4th, 2017
- No. of Shareholders
- 7,876
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Australian Stock Exchange - SEATS
- Shares in Issue
- 300,354,011
- Address
- Suite 4102, SYDNEY, 2000
- Web
- https://epsilonhealthcare.com.au/
- Phone
- +61 292517177
- Auditors
- A D Danieli Audit Pty Ltd
Upcoming Events for EPN
Similar to EPN
Acrux
Australian Stock Exchange - SEATS
AFT Pharmaceuticals
Australian Stock Exchange - SEATS
Althea group
Australian Stock Exchange - SEATS
Anatara Lifesciences
Australian Stock Exchange - SEATS
Argent BioPharma
Australian Stock Exchange - SEATS
FAQ
What is the Epsilon Healthcare share price?
As of Today at 08:32 UTC, shares in Epsilon Healthcare are trading at AU$0.02. This share price information is delayed by 15 minutes.
How has the Epsilon Healthcare share price performed this year?
Shares in Epsilon Healthcare last closed at AU$0.02 and the price had moved by -4% over the past 365 days. In terms of relative price strength the Epsilon Healthcare share price has underperformed the ASX All Ordinaries Index by -12.56% over the past year.
What are the analyst and broker recommendations for Epsilon Healthcare?
There is no consensus recommendation for this security.
What is the Epsilon Healthcare dividend yield?
Epsilon Healthcare does not currently pay a dividend.
Does Epsilon Healthcare pay a dividend?
Epsilon Healthcare does not currently pay a dividend.
When does Epsilon Healthcare next pay dividends?
Epsilon Healthcare does not currently pay a dividend.
How do I buy Epsilon Healthcare shares?
To buy shares in Epsilon Healthcare you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Epsilon Healthcare?
As of the previous close price of AU$0.02, shares in Epsilon Healthcare had a market capitalisation of .
Where are Epsilon Healthcare shares listed?
Here are the trading details for Epsilon Healthcare:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: EPN
What kind of share is Epsilon Healthcare?
Based on an overall assessment of its quality, value and momentum Epsilon Healthcare is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Epsilon Healthcare share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the Epsilon Healthcare share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Epsilon Healthcare. Over the past six months, its share price has outperformed the ASX All Ordinaries Index by +30.35%.
As of the last closing price of AU$0.02, shares in Epsilon Healthcare were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Epsilon Healthcare PE Ratio?
The Epsilon Healthcare PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at AU$0.02.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Epsilon Healthcare?
Epsilon Healthcare's management team is headed by:
- Alan Beasley - CHM
- Steven Xu - CHM
- Jarrod White - CEO
- Sonny Didugu - COO
- Jason Colquhoun - EXO
- Laura Harvey - EXO
- Diandra Phipps - EXO
- Henry Kinstlinger - SEC
- Philip Leighfield - SEC
- Lou Anthony Cattelan - NED